CIP2A is over-expressed in acute myeloid leukaemia and associated with HL60 cells proliferation and differentiation

International Journal of Laboratory Hematology

Volumn 33, Issue 3, 2011, Pages 290-298

  Wang, J ^a,b   Li, W ^c   Li, L ^a   Yu, X ^a   Jia, J ^c   Chen, C ^a  

^a SHANDONG UNIVERSITY   (China)

^b THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute myeloid leukaemia; CIP2A; Differentiation; Proliferation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA; SMALL INTERFERING RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW CELL; CANCER GROWTH; CANCER REGRESSION; CANCER RELAPSE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; CLONOGENESIS; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AUTOANTIGENS; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; GENE KNOCKDOWN TECHNIQUES; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RNA, SMALL INTERFERING; YOUNG ADULT;

EID: 79952925941     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2010.01288.x     Document Type: Article

References (28)

1. Ahn Y.O., Koo H.H., Park B.J., Yoo K.Y. & Lee M.S. (1991) Incidence estimation of leukemia among Koreans. Journal of Korean Medical Science 6, 299-307.
2. Arroyo J.D. & Hahn W.C. (2005) Involvement of PP2A in viral and cellular transformation. Oncogene 24, 7746-7755.
3. Blume-Jensen P. & Hunter T. (2001) Oncogenic kinase signalling. Nature 411, 355-365.
4. Côme C., Laine A., Chanrion M., Edgren H., Mattila E., Liu X., Jonkers J., Ivaska J., Isola J., Darbon J.M., Kallioniemi O., Thézenas S. & Westermarck J. (2009) CIP2A is associated with human breast cancer aggressivity. Clinical Cancer Research 15, 5092-5100.
5. Dudley J.P., Mertz J.A., Rajan L., Lozano M. & Broussard D.R. (2002) What retroviruses teach us about the involvement of c-Myc in leukemias and lymphomas. Leukemia 16, 1086-1098.
6. Eckhardt S.G., Dai A., Davidson K.K., Forseth B.J., Wahl G.M. & Von Hoff D.D. (1994) Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc. Proceedings of the National Academy of Sciences of the United States of America 91, 6674-6678.
7. Hudson M.M., Jones D., Boyett J., Sharp G.B. & Pui C.H. (1997) Late mortality of long-term survivors of childhood cancer. Journal of Clinical Oncology 15, 2205-2213.
8. Hunter T. (1995) Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80, 225-236.
9. Janssens V. & Goris J. (2001) Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochemical Journal 353, 417-439.
10. Janssens V., Goris J. & Van Hoof C. (2005) PP2A: the expected tumor suppressor. Current Opinion in Genetics & Development 15, 34-41.
11. Jemal A., Ward E., Hao Y. & Thun M. (2005) Trends in the leading causes of death in the United States, 1970-2002. Journal of the American Medical Association 294, 1255-1259.
12. Junttila M.R. & Westermarck J. (2008) Mechanisms of MYC stabilization in human malignancies. Cell Cycle 7, 592-596.
13. Junttila M.R., Puustinen P., Niemelä M., Ahola R., Arnold H., Böttzauw T., Ala-aho R., Nielsen C., Ivaska J., Taya Y., Lu S.L., Lin S., Chan E.K., Wang X.J., Grènman R., Kast J., Kallunki T., Sears R., Kähäri V.M. & Westermarck J. (2007) CIP2A inhibits PP2A in human malignancies. Cell 130, 51-62.
14. Khanna A., Böckelman C., Hemmes A., Junttila M.R., Wiksten J.P., Lundin M., Junnila S., Murphy D.J., Evan G.I., Haglund C., Westermarck J. & Ristimäki A. (2009) MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. Journal of the National Cancer Institute 101, 793-805.
15. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A. & Dick J.E. (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648.
16. Li W., Ge Z., Liu C., Liu Z., Björkholm M., Jia J. & Xu D. (2008) CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells. Clinical Cancer Research 14, 3722-3728.
17. Mertens A.C., Yasui Y., Neglia J.P., Potter J.D., Nesbit M.E. Jr, Ruccione K., Smithson W.A. & Robison L.L. (2001) Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. Journal of Clinical Oncology 19, 3163-3172.
18. Ostman A., Hellberg C. & Böhmer F.D. (2006) Protein-tyrosine phosphatases and cancer. Nature Reviews Cancer 6, 307-320.
19. Parkin D.M., Bray F., Ferlay J. & Pisani P. (2005) Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians 55, 74-108.
20. Parsons R. (1998) Phosphatases and tumorigenesis. Current Opinion in Oncology 10, 88-91.
21. Perrotti D. & Neviani P. (2006) ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia. British Journal of Cancer 95, 775-781.
22. Pui C.H. & Evans W.E. (1998) Acute lymphoblastic leukemia. New England Journal of Medicine 339, 605-615.
23. Pui C.H., Cheng C., Leung W., Rai S.N., Rivera G.K., Sandlund J.T., Ribeiro R.C., Relling M.V., Kun L.E., Evans W.E. & Hudson M.M. (2003) Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. New England Journal of Medicine 349, 640-649.
24. Sablina A.A., Chen W., Arroyo J.D., Corral L., Hector M., Bulmer S.E., DeCaprio J.A. & Hahn W.C. (2007) The tumor suppressor PP2A Abeta regulates the RalA GTPase. Cell 129, 969-982.
25. Sontag E. (2001) Protein phosphatase 2A the Trojan Horse of cellular signaling. Cellular Signalling 13, 7-16.
26. Soo Hoo L., Zhang J.Y. & Chan E.K. (2002) Cloning and characterization of a novel 90kDa 'companion' auto-antigen of p62 overexpressed in cancer. Oncogene 21, 5006-5015.
27. Van Hoof C. & Goris J. (2004) PP2A fulfills its promises as tumor suppressor: which subunits are important? Cancer Cell 5, 105-106.
28. Yang C. & Zhang X. (1991) Incidence survey of leukemia in China. Chinese Medical Journal 6, 65-70.